All News Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Market Closed - Nasdaq Other stock markets 02:00:00 07/05/2024 am IST			5-day change	1st Jan Change
2.22 ^USD	-2.20%		+7.25%	-33.33%

24/04	Coherus BioSciences, Inc. Announces Presentation of Clinical Data for CHS-114 at 2024 American Society of Clinical Oncology Annual Meeting	CI
20/03	HC Wainwright Adjusts Coherus BioSciences' Price Target to $11 From $13, Keeps Buy Rating	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024	02/05	GL
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology Annual Meeting	25/04	AQ
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04	GL
Coherus BioSciences, Inc. Announces Presentation of Clinical Data for CHS-114 at 2024 American Society of Clinical Oncology Annual Meeting	24/04	CI
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting	08/04	GL
HC Wainwright Adjusts Coherus BioSciences' Price Target to $11 From $13, Keeps Buy Rating	20/03	MT
Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss	15/03	MT
Transcript : Coherus BioSciences, Inc., Q4 2023 Earnings Call, Mar 13, 2024	14/03
Coherus BioSciences: Q4 Earnings Snapshot	14/03	AQ
Earnings Flash (CHRS) COHERUS BIOSCIENCES Reports Q4 Revenue $91.5M, vs. Street Est of $90.4M	14/03	MT
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update	14/03	GL
Coherus BioSciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/03	CI
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	07/03	AQ
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	06/03	GL
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024	06/03	AQ
North American Morning Briefing : Stock Futures -2-	04/03	DJ
North American Morning Briefing : Stock Futures Hover At Start of Busy Week	04/03	DJ
Coherus BioSciences Completes $170 Million Sale of Ophthalmology Franchise to Sandoz	04/03	MT
Sandoz: acquisition of Cimerli finalized	04/03	CF
Sandoz Completes Purchase of Retinal Disease Medication Cimerli from Coherus BioSciences	04/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

All News

Filters